Overview
Study for the Recording of Adherence to Treatment With Perindopril/Indapamide/Amlodipine Fixed Dose Combination
Status:
Completed
Completed
Trial end date:
2016-12-21
2016-12-21
Target enrollment:
0
0
Participant gender:
All
All
Summary
The main objective of this study is to record, in routine clinical practice, patients' adherence to treatment with Perindopril/Indapamide/Amlodipine fixed dose combination, during 4 months treatment.Accepts Healthy Volunteers?
NoDetails
Lead Sponsor:
Servier Hellas Pharmaceuticals Ltd.Treatments:
Amlodipine
Indapamide
Perindopril
Criteria
Inclusion Criteria:- Male or female, ambulatory patients >18 years old.
- Clinically diagnosed essential arterial hypertension.
- Under treatment with Perindoril/Indapamide/Amlodipine fixed dose combination.
- The patient has given his/her written consent after being informed, before his
inclusion in the study.
Exclusion Criteria:
- Secondary arterial hypertension.
- Serious end stage diseases, severe neuropsychiatric diseases, cerebrovascular event
with serious residual lesions, scheduled procedure or surgical operation or hospital
admission.
- Pregnancy, lactation or intention to become pregnant.